COO vs. WST, ALGN, XRAY, MMSI, HAE, QDEL, NEOG, ICUI, STAA, and ATRI
Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include West Pharmaceutical Services (WST), Align Technology (ALGN), DENTSPLY SIRONA (XRAY), Merit Medical Systems (MMSI), Haemonetics (HAE), QuidelOrtho (QDEL), Neogen (NEOG), ICU Medical (ICUI), STAAR Surgical (STAA), and Atrion (ATRI). These companies are all part of the "health care supplies" industry.
Cooper Companies (NASDAQ:COO) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.
Cooper Companies has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, West Pharmaceutical Services has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500.
West Pharmaceutical Services has a net margin of 19.42% compared to Cooper Companies' net margin of 9.11%. West Pharmaceutical Services' return on equity of 20.57% beat Cooper Companies' return on equity.
Cooper Companies received 347 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.56% of users gave Cooper Companies an outperform vote while only 55.74% of users gave West Pharmaceutical Services an outperform vote.
24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 2.0% of Cooper Companies shares are held by company insiders. Comparatively, 0.5% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Cooper Companies presently has a consensus price target of $111.42, indicating a potential upside of 18.14%. West Pharmaceutical Services has a consensus price target of $435.20, indicating a potential upside of 31.32%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts clearly believe West Pharmaceutical Services is more favorable than Cooper Companies.
West Pharmaceutical Services has lower revenue, but higher earnings than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
In the previous week, Cooper Companies had 15 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 24 mentions for Cooper Companies and 9 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.06 beat Cooper Companies' score of 0.67 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.
Summary
West Pharmaceutical Services beats Cooper Companies on 11 of the 18 factors compared between the two stocks.
Get Cooper Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cooper Companies Competitors List
Related Companies and Tools
